Home » Topics » Regulatory

Regulatory
RSS

Zomig-ZMT now available in U.S. for treatment of migraine

June 8, 2001

Celltech launches Metadate CD for ADHD in U.S.

June 6, 2001

Oral suspension of Trileptal for epilepsy approved by FDA

June 5, 2001

New dose of Teveten now available in Canada

May 31, 2001

Takeda's Ixense approved in Europe for ED

May 30, 2001

Novartis launches Foradil Aerolizer in the U.S.

May 30, 2001

Femara approved in Canada as first-line treatment for advanced breast cancer

May 24, 2001

FDA accepts for review Roche's sNDA for new Xenical indication

May 23, 2001

Effexor gains new FDA labeling approval regarding relapse

May 21, 2001

Statistically significant reductions in BP reported for enalapril/nitrendipine

May 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...